PrZepbound Kwikpen
Tirzepatide 2.5mg
Prescribed by licensed professionals and delivered free to your door through Stealth Health.
Tirzepatide is a prescription injectable medication for chronic weight management. It helps reduce appetite and improve metabolic function.
- Supports significant weight loss
- Helps reduce appetite
- May improve metabolic health
- Convenient once-weekly injection
Indication & Clinical Use
Tirzepatide is indicated for chronic weight management in adults. This includes individuals with a body mass index (BMI) of 30 kg/m² or greater (obesity), or a BMI of 27 kg/m² or greater (overweight) with at least one weight-related comorbidity. Examples of comorbidities include hypertension, dyslipidemia, type 2 diabetes mellitus, or obstructive sleep apnea. It should be used as an adjunct to a reduced-calorie diet and increased physical activity.
Dosing & Administration
Tirzepatide is administered as a subcutaneous injection once weekly. The starting dose is typically 2.5 mg. Your healthcare provider will gradually increase the dose over several weeks to reach an effective maintenance dose. Always follow your provider's specific instructions.
What It Is
Tirzepatide is a prescription injectable medication. It is used for chronic weight management in adults. This includes individuals with obesity or those who are overweight with at least one weight-related comorbidity.
It is intended for use alongside a reduced-calorie diet and increased physical activity.
How It Works
Tirzepatide is a dual GIP and GLP-1 receptor agonist. This means it mimics the action of two natural gut hormones. These hormones help regulate blood sugar, slow gastric emptying, and signal to the brain that you are full.
This can lead to reduced food intake and weight loss.
Benefits
Patients using Tirzepatide in clinical studies have experienced significant weight loss. This medication can help individuals achieve and maintain their weight loss goals.
It may also lead to improvements in certain weight-related health conditions. These include blood pressure and cholesterol levels.
Important Safety Information
Serious Warnings & Precautions
Tirzepatide may cause serious side effects. These include pancreatitis, gallbladder problems, and acute kidney injury. There is a potential risk of thyroid C-cell tumors, as observed in animal studies. Report any severe abdominal pain, vision changes, or signs of an allergic reaction to your provider immediately. Discuss your medical history thoroughly before starting treatment.
Contraindications
Do not use Tirzepatide if you or your family have a personal history of medullary thyroid carcinoma (MTC). Do not use if you have Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). Do not use if you have a known hypersensitivity to Tirzepatide or any of its components. It is not for use in patients with type 1 diabetes.
Common Side Effects
The most common side effects include nausea, diarrhea, vomiting, constipation, and abdominal pain. These side effects are often mild to moderate and may decrease over time as your body adjusts to the medication. If side effects persist or worsen, contact your healthcare provider.
Drug Interactions
Tirzepatide can affect the absorption of oral medications due to delayed gastric emptying. Use caution when co-administering with oral contraceptives, as their efficacy may be reduced. Discuss all medications, supplements, and herbal products you are taking with your healthcare provider to identify potential interactions.
Important Safety Information
Before starting Tirzepatide, discuss your full medical history with your healthcare provider. This includes any history of thyroid problems, pancreatitis, kidney disease, or diabetic retinopathy. Do not share your Kwikpen with others, even if the needle is changed. Sharing pens can result in the transmission of infection. This medication is not a substitute for insulin and should not be used in patients with type 1 diabetes. Monitor for signs of serious side effects and seek medical attention if they occur.
Reporting Suspected Side Effects
Canada: Report suspected adverse reactions to Health Canada — Canada Vigilance Program at 1-866-234-2345. More information here.
United States: Report suspected adverse reactions to FDA MedWatch at 1-800-FDA-1088. More information here.
Ready to get started with Zepbound Kwikpen?
Complete a quick online assessment and a licensed prescriber will review your profile.
Start Your Free Assessment